期刊文献+

空腹血糖受损与糖耐量受损者胰岛β细胞功能及胰岛素抵抗的比较 被引量:4

Study on the pancreatic β cell function and insulin resistance in impaired fasting glucose and impaired glucose tolerance
下载PDF
导出
摘要 目的:比较空腹血糖受损与糖耐量受损者胰岛β细胞功能及胰岛素抵抗的不同。方法:选择正常糖耐量者40例,空腹血糖受损者32例,糖耐量受损者38例。测体重指数、血压、血脂、空腹及糖负荷后的血糖、血胰岛素。用稳态模式胰岛素抵抗指数HOM A-IR抵抗作为胰岛素抵抗指标,稳态模式HOM A-β作为基础胰岛素分泌指标,糖负荷30m in净增胰岛素/净增葡萄糖作为早期胰岛素分泌指数。结果:空腹血糖受损组HOM A-IR较耐量受损组增高,差异有显著性(P<0.05)。空腹血糖受损组HOM A-β较糖耐量受损组降低,差异有显著性(P<0.05)。糖耐量受损组净增胰岛素/净增葡萄糖与空腹血糖受损组比较有下降,但差异无统计学意义。结论:空腹血糖受损人群较糖耐量受损人群有着更严重的胰岛素抵抗,空腹血糖受损人群基础状态下胰岛β细胞功能受损,而糖耐量受损人群的早期胰岛素分泌反应减弱。 Objective To compare the difference of pancreatic β-cell function and insulin resistance between impaired fasting glucose and impaired glucose tolerance. Methods Forty patients with normal glucose tolerance, 32 with impaired fasting glucose and 38 with impaired glucose tolerance were measured their levels of body mass index, blood pressure, plasma glucose, lipids and insulin. Homeostasis model assessment (HOMA) was applied to assess the status of insulin resistance (HOMA- IR) and basic function of pancreatic β-cell (HOMA-β cell). While insulinogenic index, the ratio of the increment of insulin to that of plasma glucose 30 minutes after a glucose load, △I30/△G30 were used to evaluate the insulin secretion in the early stage. Results In the group of impaired fasting glucose, HOMA-IR was greatly increased, and HOMA-β was decreased, with a significant difference compared with those in the group of impaired glucose tolerance (P〈0.05). There was no significant difference in △I30/△G30 between two groups. Conclusion Insulin resistance is more severe in impaired fasting glucose group than in impaired glucose tolerance group. The impaired fasting glucose subjects have basic insulin secretion deficiency. The impaired glucose tolerance subjects have insulin secretion weakening in the early stage.
作者 佟莉
出处 《实用诊断与治疗杂志》 2006年第6期419-420,共2页 Journal of Practical Diagnosis and Therapy
关键词 空腹血糖受损 糖耐量受损 胰岛Β细胞功能 胰岛素抵抗 Impaired fasting glucose impaired glucose tolerance pancreatic β-cell function insulin resistance
  • 相关文献

参考文献6

二级参考文献22

  • 1Prigeon R J,Jacobson R K,Porte D,et al. Effect of sulfonylurea withdrawal on proinsulin levels, B-cell function, and glucose disposal in subjects with non-insulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab,1996,81:3295.
  • 2Davies M J,Metcalfe J,Day J L,et al. Effect of sulphonylurea therapy on plasma insulin, intact ang 32/33. split proinsulin in subjects with type 2 diabetes mellitus[J]. Diabet Med, 1994,11:293.
  • 3Raehman J, Levy J C, Barrow B A, et al. Relative yperproinsulinemia of NIDDM persists despite the reduetion of hyperglycemia with insulin or sulfonylurea therapy[J]. Diabetes,1997,46:1557.
  • 4Stone L M,Kahn S E,Fujimoto W Y,et al. A variation at position 30 of the B-cell gluckonase gene promoter is associated with reduced b-cell function in middle-aged Japaness-American men[J]. Diabetes, 1999,45 : 42.
  • 5Holman R R,Robert Turner,Rury Holman, et al. UKPDS Study[J]. Diabetes Care, 1999,22 : 966.
  • 6Del Prato S, Tiengo A. The importance of first-phase insulin secretion :implications for the therapy of type 2 diabetes mellitus[J]. Diabetes Metab Res Rev,2001,17(3) : 164.
  • 7贾伟平,中国糖尿病杂志,1995年,3卷,11页
  • 8Gomez-Perez FJ,Aguilar-Salinas CA,Lopez-Alvarenga JC,et al.Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care,1998,21:1886-1888.
  • 9Gimeno SG,Ferreira SR ,Franco LJ,et al. Comparison of glucose tolerance categories according to the World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. Diabetes Care, 1998,21 : 1889-1892.
  • 10Tominaga M,Eguchi H,Manaka H,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease,but not impaired fasting glucose. Diabetes Care, 1999,22 : 920-924.

共引文献279

同被引文献36

  • 1王先令,陆菊明,潘长玉.不同糖耐量水平者血清C反应蛋白水平及阿卡波糖干预的影响[J].中华内分泌代谢杂志,2003,19(4):254-256. 被引量:43
  • 2石福彦,杜群,田改生,李子玲,孙春梅,李畅蕾,董智慧,刘美英.空腹血糖受损人群临床与代谢指标特征[J].中华全科医师杂志,2006,5(6):367-369. 被引量:10
  • 3乐岭,向光大,赵林双,孙慧伶.老年糖代谢异常患者血清炎症因子的变化[J].中国慢性病预防与控制,2006,14(4):259-261. 被引量:6
  • 4杨娥,余学英,莫足娥,叶宝霞,李雪锋.不同方式的干预措施对糖耐量受损患者的影响[J].实用诊断与治疗杂志,2007,21(4):269-270. 被引量:7
  • 5Pradhan A D, Manson J E, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus[J].JAMA,2001,286(3):327-334.
  • 6Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study[J].Diabetes Care, 2003,26 (4) 1251-1257.
  • 7Oberbach A, Tonjes A, Kloting N, et al. Effect of a 4-week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance [J].EurJ Endocrinol,2006,154(4):577-585.
  • 8Shepherd J, Cobbe SM, Ford I, Isles CG, et al. Prevention of coronary heart disease with pravastin in men with hypercholeterolemia[J].N Engl J Med, 1995,333(20):1301- 1307.
  • 9Tan C B, War M S, Tan C F, et al. C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance[J]. Diabetes Care, 2003, 26(12):2323-2326.
  • 10Wen C P, Ling H, David T Y, et al. Increased mortality risks of pre-diabetes (impaired fasting Glucose) in Taiwan[J]. Diabetes Care,2005,28(11) :2756-2761.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部